CNV2197944 Uses, Dosage, Side Effects and more
CNV2197944 is under investigation in clinical trial NCT01893125 (Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy).
| Trade Name | CNV2197944 |
| Generic | CNV-2197944 |
| CNV-2197944 Other Names | CNV2197944 |
| Type | |
| Formula | C19H20F3N3O3S |
| Weight | Average: 427.44 Monoisotopic: 427.117747179 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
